2026. CRISPR-CAS9 GENE EDITING THERAPEUTICS: FROM FIRST APPROVAL TO EXPANDING CLINICAL PIPELINE. Global Conference on Medical and Health Sciences. 1, 9 (Sep. 2026), 29–36.